Roche

News

Keeping up the PACE at the Scottish Medicines Consortium

After a nay from NICE, Scotland says aye to J&J’s Spravato

NHS patients with treatment-resistant depression in Scotland will be able to access Johnson & Johnson’s Spravato, a drug that has been turned down twice by NICE for patients in England.

News

Blueprint and Roche take on Lilly as FDA approves RET-target...

Cancer drugs firm Blueprint Medicines has gained a second US approval, with its Gavreto (pralsetinib) daily pill that targets non-small cell lung cancer with RET fusion mutations.<

News

England trials population testing for COVID-19

England is to trial population testing for COVID-19 in places such as schools, colleges and busy public spaces.

News

Mission successful for Novartis after FDA approves ofatumuma...

It’s mission accomplished for Novartis after the FDA approved ofatumumab for multiple sclerosis, completing a project where the former cancer drug has been repurposed.

Views & Analysis

Coronavirus pharma news round-up 21/08/20

New insights into smell and taste loss symptoms, artificial intelligence and further encouraging data from a vaccine candidate hit the headlines this week as the COVID-19 coronavirus pandem

News

Regeneron recruits Roche to make COVID-19 antibody drug REGN...

Roche has agreed to help Regeneron manufacture its COVID-19 antibody cocktail REGN-COV2, which started late-stage clinical testing a few weeks ago, in a deal that could more th

After a nay from NICE, Scotland says aye to J&J’s Spravato

Blueprint and Roche take on Lilly as FDA approves RET-target...

England trials population testing for COVID-19

Mission successful for Novartis after FDA approves ofatumuma...

Coronavirus pharma news round-up 21/08/20

Regeneron recruits Roche to make COVID-19 antibody drug REGN...

Ipsen' Bylvay fluffs its lines in biliary atresia trial

Discover a new era of healthcare panel engagement: Grounded ...

Roche

Editor's Picks